AmeriLife's GS National Insurance Partners With Davies Agency to Expand Health Insurance Services in Western New York
CLEARWATER, FL / ACCESS Newswire / August 6, 2025 / GS National Insurance, a wholesale distributor of health insurance products for independent brokers and agencies, and affiliate of AmeriLife, today announced a strategic partnership with Davies Agency, a leading Medicare and health brokerage based in Orchard Park, N.Y. Per the agreement, terms of the deal were not disclosed.
"We are very excited to partner with GS National Insurance and AmeriLife, respected leaders in the Medicare and insurance industry," said Tom and Sue Davies, principals of Davies Agency, in a joint statement. "This strategic partnership marks an exciting chapter in our journey, allowing us to expand our services and deliver even greater value to our clients, partners, and community."
For more than 20 years, Davies Agency has specialized in Medicare insurance and individual and family health plans offered through the New York State of Health Marketplace. The agency is known for its personalized approach to health insurance, offering comprehensive services that include navigating Medicare Advantage Plans, Medicare Supplement (Medigap) Insurance, Part D Prescription Drug Plans, Individual Coverage Health Reimbursement Arrangements (ICHRA), and more. Davies' experienced agents, who offer face-to-face, concierge-level support, are trained to support clients with personalized support that takes the confusion out of Medicare and health insurance and helps them maximize benefits to fit their lifestyles.
The partnership with GS National and AmeriLife will provide enhanced support, expanded product offerings, and a broader range of solutions and services to agents to streamline their sales processes, grow their books of business, and serve even more clients across the region.
"It's an honor to officially welcome Tom and Sue into our family," said Brian Breisinger, founder, president, and CEO of GS National Insurance. "I've had the privilege of working alongside them for several years and have always admired their integrity, client-first mindset, and deep industry knowledge. This partnership represents a continuation of the values and service we both cherish."
"We are thrilled to strengthen our Health Distribution family through this partnership with Davies Agency," added Scotty Elliott, AmeriLife's Chief Distribution Officer for Health. "Tom and Sue have built a reputation for excellence and personalized service, which aligns perfectly with AmeriLife's commitment to providing best-in-class solutions for agents and their clients. This collaboration is yet another significant step forward in our mission to enhance the health and well-being of communities across the country."
About Davies Agency
Davies Agency is a trusted health brokerage in Orchard Park, New York, dedicated to providing personalized support and guidance in navigating Medicare and health insurance options. Their experienced agents are committed to helping clients find the best plans and secure the lowest costs. To learn more, visit DaviesAgency.net.
About GS National Insurance
Founded in 2007, GS National Insurance, an affiliate of AmeriLife, is a national wholesale distributor of insurance products for independent brokers built on the belief that simplicity, transparency, and recognition are the cornerstones for success in the insurance industry. For more information, visit GSNational.com.
About AmeriLife
AmeriLife's strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. AmeriLife develops, markets, and distributes life and health insurance, annuities, and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For over 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers through a national distribution network of over 300,000 agents, financial professionals, and more than 160 marketing organizations and insurance agencies. For more information, visit AmeriLife.com and follow AmeriLife on Facebook and LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
35 minutes ago
- Business Insider
CVS vs. UNH: Which Healthcare Stock is a Better Buy After Q2 Earnings?
CVS Health (CVS) and UnitedHealth Group (UNH), two of the largest players in the healthcare sector, recently reported their Q2 earnings, showing contrasting performances. While CVS delivered strong revenue growth and raised its full-year guidance, UnitedHealth faced challenges with declining earnings and released a cautious outlook. This article compares the two stocks to help investors decide which healthcare giant offers a better buying opportunity after the latest results. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Is CVS a Good Stock to Buy Now? CVS has shown steady performance compared to its competitors and made a strong recovery in 2025 after several challenging years. So far this year, its stock has climbed more than 45%. For Q2, the company posted results that exceeded expectations. Notably, the Health Care Benefits segment, which includes Aetna, achieved a 39% increase in adjusted operating income. In response to these positive results, CVS raised its full-year adjusted EPS guidance to a range of $6.30 to $6.40, up from the previous $6.00 to $6.20. The company is also rolling out a $2 billion, multi-year cost-saving plan, with expected 2025 savings set to fully cover rising variable costs. These strategic initiatives and financial metrics underscore CVS Health's strong position in the healthcare sector, making it an attractive option for investors seeking stability and growth. Is UNH a Good Buy Right Now? On the other hand, UnitedHealth has faced several difficulties recently. In April, it reported higher-than-expected medical costs in its Medicare division. In May, the company pulled its full-year financial forecast, and CEO Andrew Witty resigned unexpectedly for personal reasons. Earlier this month, UnitedHealth's stock hit a new 52-week low, falling 51% over the past six months. Interestingly, UnitedHealth's Q2 results added to its challenges. The company missed earnings expectations, reporting $4.08 per share compared to the $4.45 forecast. Additionally, the company issued a weaker profit guidance for the full year. This new outlook factors in the company's performance in the first half of 2025 and expected increases in medical costs for the rest of the year. Despite the challenges, UnitedHealth's steady revenue base, ongoing investments, and expectations for earnings growth in 2026 make it an attractive option for investors willing to look past short-term setbacks. However, cautious investors should monitor how the company manages cost pressures and carries out its plans going forward. Which Healthcare Stock Is a Strong Buy, According to Analysts? Using the TipRanks Stock Comparison tool, we compared these healthcare stocks. Among these companies, CVS stock has earned a Strong Buy rating from analysts, while UNH stock carries a Moderate Buy. In terms of share price appreciation, CVS's average stock price target of $81.75 offers an upside potential of 19% from current levels. In contrast, UNH's stock price forecast of $312.65 suggests a growth rate of just 1%. Conclusion Among the stocks, CVS currently stands out as the better investment option, according to analysts. It holds a stronger analyst rating, a higher projected upside, and has demonstrated solid recent performance with raised earnings guidance. While UNH remains a strong player with long-term potential, CVS's current momentum and outlook may offer a more appealing option for investors.
Business Insider
2 hours ago
- Business Insider
Not Just Buffett and Burry, But This Billionaire Investor Also Bet Big on UnitedHealth Stock (UNH) in Q2
Billionaire investor David Tepper increased his stake in the struggling health insurance giant, UnitedHealth (UNH), during Q2. His move mirrors Warren Buffett 's Berkshire Hathaway (BRK.B), which also revealed a new $1.57 billion stake in UNH stock. Further, Michael Burry's Scion Asset Management bought calls on 350,000 shares. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. UNH stock gained 14% on Friday as bullish bets from Top hedge funds boosted investor hopes for a rebound. According to a recent 13F filing, Tepper's Appaloosa Management LP added 2.3 million shares of UNH, bringing the total value of the stake to $764 million. This makes UNH the fund's second-largest holding after Chinese e-commerce giant Alibaba (BABA). Tepper's bet comes at a turbulent time for UnitedHealth, which is dealing with a criminal probe into Medicare billing, a CEO shakeup, and the aftermath of a massive cyberattack. UNH stock has plunged about 40% year-to-date. Tepper Shifts Strategy on China Tepper's bet on UNH aligns with his investment strategy, which involves making bold bets on companies that others are avoiding. It is similar to his earlier investment in Chinese stocks, which he began buying last year when many investors were pulling back over economic and geopolitical concerns. It must be noted that those investments paid off as China's MSCI benchmark surged 46% over the past year due to Beijing's economic stimulus efforts. However, Tepper is now taking a more cautious approach. The fund reduced its holdings in major Chinese companies amid rising trade tensions. Appaloosa cut its stake in Alibaba by over 20% and also trimmed its positions in (JD), Baidu (BIDU), and PDD Holdings (PDD). Tepper's Other Bullish Bets Apart from UNH, the investor also ramped up his stake in Nvidia (NVDA), adding 1.45 million shares for a total of 1.75 million. This 483% increase brings the position's value to over $276 million. Also, he made some notable new investments last quarter. These include tech giant Intel (INTC), with 8 million shares valued at $179.2 million, and aerospace and defense company RTX (RTX), with 585,000 shares worth $85.4 million. The third-largest new buy is health information technology and clinical research provider IQVIA Holdings (IQV), with 300,000 shares valued at $47.3 million. Is UNH a Good Buy Right Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, four Holds, and two Sells assigned in the last three months. At $312.65, the average UnitedHealth stock price target implies a 2.17% upside potential.
Business Insider
3 hours ago
- Business Insider
Japanese auto giant aims to make Africa's richest country the hub of continental truck production
The South African arm of Japanese automaker Isuzu Motors is positioning itself as a manufacturing hub for commercial trucks on the continent Isuzu Motors South Africa plans to become Africa's hub for truck manufacturing to boost production and local sourcing. The company conducts discussions with Japan to relocate more commercial truck production to South Africa. Isuzu is targeting West Africa for scaling up truck exports and aims for 45% production localisation. The South African arm of Japanese automaker Isuzu Motors is positioning itself as a manufacturing hub for commercial trucks on the continent, part of a strategy to boost production volumes and deepen the use of locally sourced parts. Billy Tom, President and CEO of Isuzu Motors South Africa, told Reuters that he has been in discussions with Japan regarding the relocation of more production to Africa. Isuzu has already run successful trials of locally building truck bodies, though it still imports some from China and the Middle East. While export volumes for trucks remain small, Isuzu already ships pickups to more than 30 countries in Africa. Tom said the company is targeting West Africa as a starting point for scaling up truck exports. Isuzu has set an ambitious target to grow its African production volumes to 45%, up from about 15% six years ago and the current 22–23%. South Africa's auto industry, home to seven major manufacturers including Volkswagen, Toyota, and Mercedes-Benz ( faces mounting pressure from surging vehicle imports, particularly from China. Low domestic sales of locally assembled cars, coupled with sluggish local content levels, have already forced 12 company closures and wiped out more than 4,000 jobs in the past two years, Trade Minister Parks Tau said. The country produced 515,850 vehicles in 2024, well below the South African Automotive Masterplan 2035 target of 784,509. Adding to the pressure, South Africa's vehicle exports to the U.S. have collapsed this year, plunging 73% in the first quarter and falling even further, 80% in April and 85% in May, industry data shows.
